| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > Email Marketing > B2B Email Marketing: Still THE Killer App! |
|
Main Subject - B2B Email Marketing: Still THE Killer App!
Email marketing is far from dead, no matter what the so-called experts say. In fact recent software applications are putting the power of Fortune 500 companies in the hands of Main Street businesses - leveling the playing field a According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product t last. There are challenges to be sure, such as creating and maintaining an opt-in list - so you won't jeopardize your company's good name and your established goodwill in the marketplace. Delivering the message you want to the ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in people you want to receive it - perhaps a special offer for people renewing their service contracts that's only available to people beyond the first year after purchase. And properly managing responses so the right actions are tr lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. iggered automatically! But finally these issues can be handled cost effectively, so it's not the big guys who are the only ones in a position to control email marketing anymore. Here are three of the benefits of B2B email marke here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ing - besides the obvious, that it is cheap, immediate, and interactive. First, in the world of b2b your target prospect is probably at their desk 12 hours a day - or carrying their Blackberry or other handheld device - so you w d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ll most likely reach them immediately - as soon as the message is sent. If they trust you (the From:) they'll open your message the same day it's sent. If the first message they see (the Subject:) is compelling they'll read it. ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc You just can't compare this to any other form of communications. Second, email integrates seamlessly into your total marketing campaign. You can use it to convert known suspects into prospects by getting them to request informat easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi on relevant to your campaign message - perhaps moving them along the buying cycle to prospect. Follow up email can be used to qualify them and even turn them into 1st level customers. Now, when your sales people contact them by p nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically hone of for that matter in person - they are contacting a customer not making a cold call. Third, In business virtually everything is about marketing. Your email newsletter and other regular communications for example. By imbedd and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ng links in your regular email that lead to special offers, limited availability opportunities etc. each time you touch a prospect or customer becomes a bit of a marketing opportunity. The key to success in b2b email marketing i ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi your list and it can be a challenge to build an opt-in list of email addresses and then manage them in such a way that the list grows not shrinks. One way to build a list that grows is to ask permission before putting people on ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a the list. Successful marketing in the 21st Century will be permission based marketing. The days of intrusion marketing are over, some marketers just don't know it yet. Be the first company you know to adopt the strategy that wil dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod guarantee that people will be happy and prepared to hear from you. You no doubt have the phone street addresses of your customers. When the completed forms in the recent past you probably asked for their email address as well. cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin Be careful how you use it. Only you and your relationship with your customers will tell you if it's OK to add them to your email campaigns, without their specific approval. If you're like most business people I know, you will be tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen better served with a service that completely automates the entire email marketing process. One that collects the email address and the other information you're looking for, sends the right email messages to the right people on th t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel right list, and then handles the responses - with little additional overhead, and without having to take someone off the floor to do it all. And finally you'll want a service that allows people to be included in various kinds o ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust f scheduled mailings at the time they are added to the list - or as they move through the sales cycle. For example a prospect requests inclusion on an announcement list for a product scheduled for future release. Once released an y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products they purchase the product they would be automatically removed from that list - so they will not keep getting announcements for something they've already bought. And if the new product has add ons they can be systematically remi . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de nded of them and removed when they purchase them or turn them down. And in either case reminded when their warranty is about to expire so they'll automatically renew it. Marketing is not just about getting the first sale - it's elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip lso about converting suspects into prospects, prospects into buyers and buyers into key accounts. B2B email marketing is the killer app for the 21st Century - the early part at least, when it is done with permission and precision tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How to Share Important Documents in a Spam-Free Environment Client or Customer? There Really Is A Difference Does Your Strategic Plan Include Revenue Goals Per Employee?
|